FeesSafety
Pluang+

Scholastic faces securities fraud probe after missing earnings and revenue targets

Market News
29 Oct 2026, 17:00 WIB
PRNewsWire
View Source
Bearish
Scholastic faces securities fraud probe after missing earnings and revenue targets

Pomerantz LLP is investigating Scholastic Corporation for potential securities fraud following the company's report of a $3.63 per share loss, worse than expected, and a 4% revenue decline. The Education segment saw a 24% drop due to tighter school budgets, causing Scholastic's stock to fall 7.41%. The investigation will determine if Scholastic and its executives engaged in unlawful business practices, impacting investors. Investors are encouraged to contact Pomerantz LLP for more information about joining the class action.

Regarding Scholastic Corporation, here is Pluang's Consumer Cyclical sector market snapshot as of Oct 29, 2026 21:02 WIB: Out of 134 priced US stocks, 111 rose and 22 fell. Notable movers include CROX at USD 147.35 with a 23.11% increase and 100% buy order activity, CVNA at USD 68.74 up 16.41% but with 95% sell orders, and NCLH at USD 17.88 rising 11.33%.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App